E-LIB Suche - Ergebnisse für: Oo, Charles

1

Evaluating the status of antibiotic approvals and readiness..:

Oo, Charles ; Zhang, Xiaoping ; Sy, Sherwin K.B.
Drug Discovery Today. 28 (2023) 8 - p. 103674 , 2023

Link: https://doi.org/10.1016/..

2

Physiologically-based pharmacokinetic modeling to inform do..:

Zhang, Jiayuan ; Song, Chu ; Wu, Mengyuan...
European Journal of Pharmaceutical Sciences. 185 (2023) - p. 106443 , 2023

Link: https://doi.org/10.1016/..

3

Prediction of Tissue Exposures of Meropenem, Colistin, and ..:

Zhu, Shixing ; Zhang, Jiayuan ; Lv, Zhihua...
Clinical Pharmacokinetics. 61 (2022) 10 - p. 1427-1441 , 2022

Link: https://doi.org/10.1007/..

4

Metabolomic profiling of polymyxin-B in combination with me..:

Zhu, Shixing ; Zhang, Jiayuan ; Song, Chu...
Frontiers in Microbiology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

5

The combination effect of meropenem/sulbactam/polymyxin-B o..:

Zhang, Jiayuan ; Diao, Shuo ; Liu, Yanfei...
Frontiers in Microbiology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

6

Revamping the ever-changing landscape of drug development p..:

Oo, Charles ; Ameer, Barbara
Drug Discovery Today. 26 (2021) 6 - p. 1337-1339 , 2021

Link: https://doi.org/10.1016/..

7

A Time of Optimism: Targeted Immunotherapeutics as the Long..:

Oo, Charles ; Noveck, Robert J.
Therapeutic Innovation & Regulatory Science. 54 (2020) 2 - p. 444-446 , 2020

Link: https://doi.org/10.1007/..

8

Learning and augmenting natural processes: potential means ..:

Oo, Charles ; Sy, Sherwin K.B.
Drug Discovery Today. 25 (2020) 1 - p. 1-3 , 2020

Link: https://doi.org/10.1016/..

9

A Time of Optimism: Targeted Immunotherapeutics as the Long..:

Oo, Charles ; Noveck, Robert J.
Therapeutic Innovation & Regulatory Science. , 2019

Link: https://doi.org/10.1177/..

10

Fixed-dose combinations: a potential means to boost drug de..:

Oo, Charles ; Sy, Sherwin K.B.
Drug Discovery Today. 23 (2018) 3 - p. 457-459 , 2018

Link: https://doi.org/10.1016/..

11

Proposed Strategies for the Integration of Genomics in Prim..:

Oo, Charles ; Noveck, Robert J.
The American Journal of Medicine. 129 (2016) 7 - p. e87 , 2016

Link: https://doi.org/10.1016/..

12

There is no better time than the present: nanotechnology as..:

Oo, Charles ; Tsai, Jui-Chen ; Kao, H. Danny
Drug Discovery Today. 20 (2015) 6 - p. 645-647 , 2015

Link: https://doi.org/10.1016/..

13

A personal perspective of orphan drug development for rare ..:

Oo, Charles ; Rusch, Lorraine M.
The Journal of Clinical Pharmacology. 56 (2015) 3 - p. 257-259 , 2015

Link: https://doi.org/10.1002/..

14

Does Erythromycin Have Anti‐Inflammatory Effects Independen..:

Oo, Charles ; Shah, Bharti
The Journal of Clinical Pharmacology. 52 (2012) 4 - p. 613-614 , 2012

Link: https://doi.org/10.1177/..

15

A feasibility study of differential delivery of levodopa es..:

Itoh, Soichi ; Oo, Charles
Journal of Pharmaceutical Sciences. 99 (2010) 1 - p. 227-233 , 2010

Link: https://doi.org/10.1002/..